High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis
(Q37342927)
scientific article published on 20 June 2008
scientific article published on 20 June 2008
Language:
Current Data About
High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis